Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis. - Wikidata - wikimedia - TriplyDB

Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.

Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.

http://www.wikidata.org/entity/Q43711419

about

Treatment for lupus nephritis Treatment for lupus nephritis Hematopoietic stem cell transplantation for auto immune rheumatic diseases Role of immunosuppressive therapy for the treatment of multiple sclerosis A treatment algorithm for children with lupus nephritis to prevent developing renal failure Long-term data on corticosteroids and mycophenolate mofetil treatment in lupus nephritis.Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review.An adult case of severe steroid-resistant Henoch-Schönlein purpura nephritis treated with intravenous cyclophosphamide and tonsillectomy Umbilical cord mesenchymal stem cell transplantation in active and refractory systemic lupus erythematosus: a multicenter clinical study Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis.Pin1-Targeted Therapy for Systemic Lupus Erythematosus Recent clinical trials in lupus nephritis.Cyclophosphamide and lupus nephritis: when, how, for how long?Efficacy of long-term maintenance therapy with mycophenolate mofetil in lupus nephritis.Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study.Current concepts for the management of systemic lupus erythematosus in adults: a therapeutic challenge Mesenchymal stem cells for the treatment of systemic lupus erythematosus: is the cure for connective tissue diseases within connective tissue?Paradoxical effects of all-trans-retinoic acid on lupus-like disease in the MRL/lpr mouse model.Treatment of severe proliferative lupus nephritis: the current state.Lupus nephritis: current issues.EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis.Bone loss in patients treated with pulses of methylprednisolone is not negligible: a short term prospective observational study.IgG immunoadsorption reduces systemic lupus erythematosus activity and proteinuria: a long term observational study.Safety and efficacy of intravenous pulse cyclophosphamide in acute steroid refractory inflammatory bowel disease.Pulse cyclophosphamide therapy in the management of patients with macular serpiginous choroidopathy.Aspergillus-associated cerebral aneurysm successfully treated by endovascular and surgical intervention with voriconazole in lupus nephritis patient.Cyclophosphamide: new approaches for systemic lupus erythematosus.Lessons learned from anti-CD40L treatment in systemic lupus erythematosus patients.Randomized controlled trials in systemic lupus erythematosus: what has been done and what do we need to do?Ovarian failure in systemic lupus erythematosus patients treated with pulsed intravenous cyclophosphamide.Treatment of lupus nephritis with abatacept: the Abatacept and Cyclophosphamide Combination Efficacy and Safety Study.Understanding lupus nephritis: diagnosis, management, and treatment options.Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation Prognostic factors in lupus nephritis.Cyclophosphamide in lupus nephritis.Lupus nephritis: induction therapy.American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis Blood stem cells as therapy for severe lupus.Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis.Basic immunosuppressive drugs outside solid organ transplantation.

P2860

Q24202572-1B530DDD-1601-45CB-8FFE-95785362C9E0 Q24247408-0334F29E-5312-4DD6-B880-19FE81C70079 Q26751425-1668DD94-3AA6-4F26-A6D6-3E442E63D387 Q26827467-D0F90E72-0B36-465F-9596-3863DE7E84BE Q27026880-6F953E59-4BAB-4385-ADD6-FC932A18915B Q30577281-E01723CE-5771-4098-A583-F1D9ADD6E48A Q33521057-33394D66-0581-4115-8AD9-DE33C95DF9FC Q33622282-33AB6283-4B6B-4EF3-8E73-4C887F93C690 Q33767123-CE0BD6E1-9198-47D8-863A-F077345C1C93 Q33806541-38A05AD3-9DD4-4459-8026-E9404963E730 Q33859906-33A05830-EDA8-4C43-8CC1-3770BFD21D1F Q33924437-7434C4BA-1B7F-48C9-B730-9FB2AA6B03A3 Q34095231-14E73049-3C8B-4A7F-860F-2ECF168F29A9 Q34490782-C6C2473D-3A5C-40E6-9074-04548E7C2C03 Q34613945-0084F892-D46C-4EA1-B65F-9D2BB111109B Q34988089-5F25FF1E-F731-45A8-AAB6-9AF8B92A56CC Q35155191-31D3692F-CEEF-4B28-AA23-F2ADA3432CC0 Q35182476-4CF0CC17-CCE7-4555-93B6-93CA33472DC7 Q35201234-BE14E55B-EFC9-4BC5-B267-46E0B47B3669 Q35553102-61F0A18E-1E15-49E7-82C0-7D9D3CA3F9F8 Q35554126-32976AED-0EB0-4501-89BD-9EE370E6DE7E Q35554374-E0CF2C52-01A5-4DC0-ABE1-1187E838DC6F Q35555714-A195C0B3-624D-4120-B756-A04BB3DF9207 Q35595464-B02444A1-A25C-4706-BE9B-B625785FB6F0 Q35722478-3A9F78C4-92EE-4270-A2A0-41144A3039E6 Q35778456-5AA8005D-2505-41E1-84F2-8148A3D295BD Q35824515-1A557DF4-0060-4B07-B80D-C552F1DC4925 Q35824531-DE885E0A-9D97-4F10-BC02-2F7AE9437D4B Q35824537-610FF614-EE5F-4265-9159-708329066D0C Q35918369-E346A749-A1D3-46DC-B193-6F233BF5B339 Q35927877-34B41C53-CBB7-4714-B2E5-F30412FEE3D4 Q36008840-D5692FBF-9AA5-48A5-834A-5ACBC1F5F9E6 Q36020897-DF9C8F2E-4AC2-4795-9B20-A411F39ABFAC Q36054839-3654BCED-2986-4972-8CF9-3968329A6D30 Q36054857-905AA8F5-BF95-49DB-A783-B10C462960FD Q36085856-65E5A440-AE2C-417E-9A9B-0FE8CF3A467E Q36221407-1C421C90-7C54-46AD-B43C-8DDBAB0C16B6 Q36239643-7CA78075-7101-41E1-8841-F4D3C2B1442C Q36302245-45E97D22-4B41-4706-A93B-139040FEB635 Q36407314-5F39C92D-21A1-4CAD-92C1-38785675E274

P2860

Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.

http://www.wikidata.org/entity/Q43711419

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

Combination therapy with pulse ...... patients with lupus nephritis.

@en

Combination therapy with pulse ...... patients with lupus nephritis.

@nl

type

label

Combination therapy with pulse ...... patients with lupus nephritis.

@en

Combination therapy with pulse ...... patients with lupus nephritis.

@nl

prefLabel

Combination therapy with pulse ...... patients with lupus nephritis.

@en

Combination therapy with pulse ...... patients with lupus nephritis.

@nl

P1433

Q43711419-E8D54660-70A5-4286-AB67-F609045B9B1F

P1476

Q43711419-432E8932-0F6F-40D8-9865-52ECC31C14F8

P2093

Q43711419-266AF248-3C63-4993-90BB-2DC9488D258A

Q43711419-3ABAA260-D597-47B6-9C54-311A4AAE20D2

Q43711419-431B99EB-DF8A-4E28-9C28-115BF169ADD1

Q43711419-5A1CF811-F367-485F-9F3A-316A35BF0C3F

Q43711419-6361DEA4-F09C-41AF-9F31-2E900773B81C

Q43711419-64B99148-4358-467F-A4D7-9B3E82E2A201

Q43711419-A9FFF675-649E-4CC6-8A15-6F52FCD0F25F

Q43711419-B61BFB29-CDDD-4FDC-BBCA-C7F190127D2C

Q43711419-B9C3B716-8BA2-4568-9900-A37CD1D12FD5

Q43711419-BBB6D849-A30E-4B9C-B3EA-5F5245CAB839

P304

Q43711419-FE439FA7-6E7E-49E8-8B83-DBC25E090619

P31

Q43711419-1D1E5377-CC7F-4F7F-8F5E-4D03406C2E08

P356

Q43711419-CDD15ED9-5274-4992-81D9-2C38D510E05B

P407

Q43711419-FFBF9D17-CACB-4F57-BE0C-F6C3D64D7281

P433

Q43711419-FA7033C6-CB0B-4287-9D2A-52A1A45F6A6B

P478

Q43711419-18A04CB3-2BD9-4F66-8600-4A0BE65DE2B3

P577

Q43711419-C8687767-83E4-4DCE-8F3A-8CCAAC429CDD

P698

Q43711419-E6206F6F-82D5-4177-8DD0-E370BCE37662

P356

0003-4819-135-4-200108210-00009

P1433

Annals of Internal Medicine

P1476

Combination therapy with pulse ...... patients with lupus nephritis.

@en

P2093

Austin HA

http://www.w3.org/2001/XMLSchema#string

Balow JE

http://www.w3.org/2001/XMLSchema#string

Boumpas DT

http://www.w3.org/2001/XMLSchema#string

Collins L

http://www.w3.org/2001/XMLSchema#string

Crane M

http://www.w3.org/2001/XMLSchema#string

Danning CL

http://www.w3.org/2001/XMLSchema#string

Gourley MF

http://www.w3.org/2001/XMLSchema#string

Illei GG

http://www.w3.org/2001/XMLSchema#string

Klippel JH

http://www.w3.org/2001/XMLSchema#string

Kuroiwa T

http://www.w3.org/2001/XMLSchema#string

P304

248-257

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7326/0003-4819-135-4-200108210-00009

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

135

http://www.w3.org/2001/XMLSchema#string

P577

2001-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11511139

http://www.w3.org/2001/XMLSchema#string